TRPA1 (extracellular) Blocking Peptide BLP-CC037 from Alomone Labs, Ltd.

Description

TRPA1 (extracellular) Blocking Peptide (#BLP-CC037) is the original antigen used for immunization during Anti-TRPA1 (extracellular) Antibody (#ACC-037) generation. The blocking peptide binds and 'blocks' Anti-TRPA1 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control

Product Specs
ItemTRPA1 (extracellular) Blocking Peptide
CompanyAlomone Labs, Ltd.
Price Supplier Page View Company Product Page
Catalog NumberBLP-CC037
Size40 mcg
ApplicationsWB, IHC
FormatLyophilized powder
Purity>70%
Concentration0.4 mg/ml
TypeSynthetic peptide
Domain/Region/Terminusextracellular
TargetTRPA1
NCBI Full Gene Nametransient receptor potential cation channel subfamily A member 1
NCBI Gene AliasesANKTM1, FEPS, p120, FEPS1
StorageShipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
OriginIsrael/IL

Specifications/Features

starting price for North American orders, for exact pricing view product page

Sequence

(C)NSTGIINETSDHSE, corresponding to amino acid residues 747-760 of human TRPA1

Add to Compare List

Alomone Labs, Ltd.

PO Box 4287

Jerusalem 91042

Israel

Phone: +972-2-587-2202
+972-2-587-1101

Company Profile

Website: http://www.alomone.com/

(1) Endothelial-dependent relaxation of α-pinene and two metabolites, myrtenol and verbenol, in isolated murine blood vesselsAmerican Journal of Physiology-Heart and Circulatory PhysiologyDecember 1, 2023L. Jin, Z. Xie, P. Lorkiewicz, S. Srivastava, A. Bhatnagar, D. J. ConklinRT; and, then incubated with either TRPA antibody with or without TRPA1 blocking peptide (Alomone; BLP-CC037; TRPA1 antibody:blocking peptide, 1:1 [μg/μg]; mixed and preincubated for 1 h at RT before adding onto

(2) Activation of TRPA1 in Bladder Suburothelial Myofibroblasts Counteracts TGF-β1-Induced Fibrotic ChangesInternational journal of molecular sciencesMay 30, 2023Zhao M, Ding N, Wang H, Zu S, Liu H, Wen J, Liu J, Ge N, Wang W, Zhang X.investigators [46]. For the TRPA1 antibody, pretreatment with its blocking peptide (Alomone, Jerusalem, Israel, BLP-CC037, 1:200) served as a negative control to confirm the specificity of the TRPA1 antibody. Subsequently,

(3) Allyl isothiocyanate (AITC) activates nonselective cation currents in human cardiac fibroblasts: possible involvement of TRPA1HeliyonJanuary 1, 2021Oguri G, Nakajima T, Kikuchi H, Obi S, Nakamura F, Komuro I.were incubated for overnight with primary antibody in the presence or absence of blocking peptide (BLP-CC037, Alomone Labs) diluted with 1% bovine serum albumin in PBS into 1:400. Alexa Fluor 555 labeled Donkey

Be the First to Write a Review!